| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.29 | 0.07 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.055 | 0.08 |